Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Charioteer Pharmaceutical operates as a leading Chinese manufacturer of active pharmaceutical ingredients and intermediates for both generic and branded pharmaceuticals. The company holds cGMP certifications and supplies APIs globally for antiviral agents, anti-inflammatory drugs, cardiovascular agents, and oncology products. It has passed regulatory inspections by authorities such as the FDA and EMA for several key products. No proprietary clinical results; business model centers on contract manufacturing rather than drug development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhejiang Charioteer Pharmaceutical.